PrimeRFP SCOUT · Federal Contract Recompete Brief

W911SR22F0014Clinical development PHASE 2 STUDY — Ology Bioservices, Inc

Ology Bioservices, Inc holds $17.4M across 7 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards under parent W911SR22D0009. Recompete timing centers on the Feb 29, 2028 PoP end — agencies typically plan 12–18 months ahead.

W6qk Acc-Apg
Awarding office
Department of Defense (DOD)
Agency
Ology Bioservices, Inc
Recipient
Feb 29, 2028
PoP end
$93M
Obligated
541715
NAICS
AN42
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract numberW911SR22F0014
Also listed asW911SR-22-F-0014
Also listed asW911SR22D0009-W911SR22F0014
AgencyDepartment of Defense (DOD)
Awarding officeW6qk Acc-Apg
IncumbentOlogy Bioservices, Inc
UEIGC2RFAZK8G64
NAICS541715
PSCAN42
Parent IDIQ / IDVW911SR22D0009
Place of performanceFREDERICK, MD
Related solicitationW911SR22R0040
PoP end (current)Feb 29, 2028
Obligated$93M

CLINICAL DEVELOPMENT PHASE 2 STUDY is a federal award for Department of Defense (DOD) held by Ology Bioservices, Inc. Estimated value $107.9M ($93M obligated). Current period of performance ends Feb 29, 2028. Place of performance: FREDERICK, MD. Related solicitation W911SR22R0040.

Recompete timing

Public
● Expiring in 517 days

Current PoP ends Feb 29, 2028 (517 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Aug 29, 2026.

Bonuses end Sept 30

Want the durability read on W911SR22F0014? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ology Bioservices, Inc — $17.4M obligated across 7 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($17.4M) · all agencies
Department of Defense (DOD)$11.6M · 67%Department of Health and Human Services (HHS)$5.8M · 33%

Related awards

Same parent · incumbent
W911SR23F0057
DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEV…
Department of Defense (DOD) · OLOGY BIOSERVICES, INC.
$67.6M
Jan 5, 2028
W911SR22F0073
DS PROCESS CHARACTERIZATION
Department of Defense (DOD) · OLOGY BIOSERVICES, INC.
$10.8M
Jan 5, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract W911SR22F0014?

W911SR22F0014 (Clinical development PHASE 2 STUDY) is a W6qk Acc-Apg award with an estimated value of $107.9M, currently held by Ology Bioservices, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W911SR-22-F-0014?

W911SR-22-F-0014 is the dashed form of PIID W911SR22F0014 (Clinical development PHASE 2 STUDY), held by Ology Bioservices, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W911SR22F0014?

W6qk Acc-Apg awarded W911SR22F0014 to Ology Bioservices, Inc.

Who is the incumbent on W911SR22F0014?

Ology Bioservices, Inc is the incumbent with $17.4M across 7 related awards in SCOUT’s public footprint. The current period of performance ends Feb 29, 2028.

When does Ology Bioservices, Inc’s W911SR22F0014 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 29, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on W911SR22F0014? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W911SR22F0014